通用名称

sulfamethoxazole/trimethoprim

儿科标签批准日期

2020/7/15 0:00:00

特定指示/秒

Postmarketing study

标签更改摘要

- A simulation conducted with data from a pharmacokinetic study in 153 infants and children demonstrated that mean steady state AUC and maximum plasma concentration of trimethoprim and sulfamethoxazole would be comparable between pediatric patients 2 months to 18 years receiving 8/40 (trimethoprim/ sulfamethoxazole) mg/kg/day divided every 12 hours and adult patients receiving 320/1600 (trimethoprim/ sulfamethoxazole) mg/day. - Postmarketing study. - Off-patent Written Request.

治疗类别

Antibacterials

立法类型

409I(BPCA)

产品说明书链接